Matt Margolis writes for PJMedia.com about a new revelation involving the Biden administration.
When Joe Biden was installed as president, he wanted one thing more than almost anything else: to be remembered as the president who beat COVID. His strategy was simple: go all in on pushing the COVID vaccines — the same vaccines he said before the election shouldn’t be trusted. Be that as it may, his decision to put all of his chips on pushing the vaccines forced his administration to make some very shady decisions.
New details emerging from a Senate investigation confirm that Biden administration officials at both the FDA and CDC knew about a significant stroke risk tied to Pfizer’s bivalent COVID-19 booster in people over 65.
They knew. And they said nothing.
Sen. Ron Johnson (R-Wis.), chairman of the Senate’s Permanent Subcommittee on Investigations, formally notified HHS Secretary Robert F. Kennedy Jr. of the findings in a letter backed by roughly 2,000 pages of federal documents.
“On August 31, 2022, the Food and Drug Administration (“FDA”) authorized the PfizerBioNTech COVID-19 bivalent booster. By late October 2022, HHS reported that approximately 14.4 million people 12 years and older had received the booster. In November 2022, federal health officials became aware of a statistically significant safety signal for ischemic stroke among individuals age 65 and older following administration of the Pfizer-BioNTech COVID-19 bivalent booster.” …
… Between November 2022 and March 2023, seven separate analyses of incoming data flagged the same stroke signal for the same vulnerable population.
Seven. Yet not a single formal warning went out. …
… Instead of warning the public, the Biden administration buried the data and hired a private contractor. In February 2023, HHS brought in Lukos LLC to run an internal program called “The Stroke Project” — a deeper dive into the data — while continuing to tell the public that the vaccines were safe.
